Considering that hepatic expression of BLNC1 is evidently elevated in the obesity and NAFLD in mice, researchers studied the effects of BLNC1 on HFD – induced hepatic steatosis. Here, PAQR9 is linked to metabolic dysfunction-associated steatotic liver disease.